Retraction
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Paper Information
Record ID:
52985
Author(s):
Journal:
Publication Date:
September 29, 2017
Retraction Date:
March 26, 2024
(1.7 year years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- German Center for Lung Research (DZL), Giessen, Germany
- University of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany
- Department of Medicine, Imperial College London, London, UK
- Assistance Publique—Hôpitaux de Paris, Service de Pneumologie, Hôpital Bicêtre, Université Paris-Sud, Laboratoire d'Excellence en Recherche sur le Médicament et Innovation Thérapeutique, Le Kremlin-Bicêtre, France
- INSERM U-999, Le Kremlin-Bicêtre, France
- Department of Cardio-Thoracic and Vascular Surgery, Heart and Lung Transplantation and Pulmonary Hypertension Unit, Foundation IRCCS Policlinico San Matteo, University of Pavia School of Medicine, Pavia, Italy
- Division of Pulmonary and Critical Care Medicine, University of California San Diego, La Jolla, CA, USA
- National Pulmonary Hypertension Service, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK
- National Heart & Lung Institute, Imperial College London, London, UK
- Department of Cardiothoracic Surgery, Papworth Hospital, Cambridge, UK
- State Key Lab of Cardiovascular Disease, FuWai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Division of Cardiovascular and Thoracic Surgery, University of California San Diego Medical Center, San Diego, CA, USA
- Actelion Pharmaceuticals, Allschwil, Switzerland
- Department of Thoracic Surgery, Kerckhoff-Clinic, Bad Nauheim, Germany
Article Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/S2213-2600(24)00029-8Additional Notes:
see: https://www.sciencedirect.com/science/article/abs/pii/S2213260024000274
Citations (252)
252
Total Citations26
Post-Retraction(10.3%)
225
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
5
Within 30 days
24
Within 1 year
0
After 2+ years
468
Days since retraction (latest)
The changing landscape of chronic thromboembolic pulmonary hypertension management
Michael M. Madani, Takeshi Ogo, Gérald Simonneau
European Respiratory Review
Open Access
Published: Dec 2017
76 citations
76 citations
2288 days before retraction
Macitentan for treatment of CTEPH: why MERIT merits attention
Adam Torbicki
The Lancet Respiratory Medicine
Published: Sep 2017
2 citations
2 citations
2388 days before retraction
Quick Stats
Total Citations:
252
Years Since Retraction:
1.7 year
Open Access:
Yes
Last Checked:
Jul 24, 2025